source
- UniQure to submit UK marketing application for Huntington's gene therapy AMT-130UniQure announced it will file a marketing application in the United Kingdom later this year for its gene therapy AMT-130 aimed at Huntington's disease. The filing follows a positive meeting with…
- Elevance blocks deposition of former Medicare Advantage chief as DOJ seeks testimonyElevance Health told the Justice Department it would not make Peter Haytaian, an outgoing executive who oversaw its Medicare Advantage plans, available for a deposition, the agency said in a letter…